Suppr超能文献

多民族人群中非酒精性脂肪性肝病的无创性检测:HELIUS 研究。

Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: The HELIUS study.

机构信息

Vascular Medicine , Amsterdam UMC location University of Amsterdam , Amsterdam , The Netherlands.

Epidemiology and Data Science, Amsterdam Public Health , Amsterdam UMC location University of Amsterdam , Amsterdam , The Netherlands.

出版信息

Hepatol Commun. 2022 Nov 5;7(1):e2109. doi: 10.1002/hep4.2109. eCollection 2023 Jan 1.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence and severity globally, prompting noninvasive testing, yet limited data exist on noninvasive liver tests (NITs) including transient elastography (TE) in ethnically diverse populations. Therefore, we studied prevalence and ethnic differences in NAFLD with NITs in the multi-ethnic HEalthy Life In an Urban Setting (HELIUS) cohort. NITs of liver steatosis (Fatty Liver Index [FLI]) and fibrosis (Fibrosis-4 index [FIB-4], and aspartate aminotransferase-to-platelet ratio [APRI]) were assessed in 10,007 participants. A subpopulation of 399 participants, selected on high-risk criteria for NAFLD (obesity, type 2 diabetes mellitus [T2DM], and/or elevated NITs), was examined with TE. FLI was ≥60 in 27.3% of 10,007 participants, indicating steatosis. Most participants (71.8%) had FIB-4 < 1.30, excluding advanced liver fibrosis, and 1.1% (n = 113) had high FIB-4 (FIB-4 ≥ 2.67), indicating likely advanced liver fibrosis. In the TE subpopulation, 37.8% and 17.3% had steatosis and fibrosis (continuation attenuation parameter [CAP] ≥ 280 dB/m, liver stiffness measurement [LSM] ≥ 7.0 kPa, respectively). Turkish participants had highest adjusted odds ratio (OR) for elevated LSM (1.72, 95% confidence interval [CI] 0.59-5.01) and Ghanaians the lowest (0.24, 95% CI 0.09-0.65). Ghanaians had lowest adjusted OR for elevated CAP: 0.18 (95% CI 0.09-0.37). In diabetics, CAP and LSM were 17.6% and 14.6% higher than in nondiabetics, respectively. Correlations of FIB-4 and APRI with LSM were absent and weak. Conclusion : Liver steatosis proxy FLI was elevated in 27.3% of this multi-ethnic population. In Turkish background and in those with T2DM, proxies for steatosis and fibrosis were high, whereas in Ghanaian background, NITs were generally low. Together, this warrants awareness for NAFLD among high-risk populations, taking ethnic background into account. The absence of clear correlation between FIB-4 and APRI with LSM questions the accuracy of these fibrosis NITs to detect advanced fibrosis in the general population.

摘要

非酒精性脂肪性肝病(NAFLD)在全球范围内的患病率和严重程度都在增加,促使人们进行非侵入性检测,但在包括瞬态弹性成像(TE)在内的多种族人群中,关于非侵入性肝试验(NITs)的有限数据仍然存在。因此,我们在多民族健康生活在城市环境(HELIUS)队列中研究了 NITs 检测的 NAFLD 的患病率和种族差异。在 10007 名参与者中评估了肝脂肪变性的 NITs(脂肪肝指数[FLI])和纤维化(纤维化-4 指数[FIB-4]和天冬氨酸氨基转移酶与血小板比值[APRI])。根据 NAFLD 的高风险标准(肥胖、2 型糖尿病[T2DM]和/或升高的 NITs)选择了 399 名参与者的亚组,并用 TE 进行检查。10007 名参与者中有 27.3%的 FLI≥60,表明存在脂肪变性。大多数参与者(71.8%)的 FIB-4<1.30,排除了晚期肝纤维化,而 1.1%(n=113)的 FIB-4较高(FIB-4≥2.67),表明可能存在晚期肝纤维化。在 TE 亚组中,37.8%和 17.3%的参与者存在脂肪变性和纤维化(连续衰减参数[CAP]≥280dB/m,肝硬度测量[LSM]≥7.0kPa)。土耳其参与者的 LSM 升高的调整后优势比(OR)最高(1.72,95%置信区间[CI]0.59-5.01),加纳参与者最低(0.24,95%CI0.09-0.65)。加纳人 CAP 升高的调整后 OR 最低:0.18(95%CI0.09-0.37)。在糖尿病患者中,CAP 和 LSM 分别比非糖尿病患者高 17.6%和 14.6%。FIB-4 和 APRI 与 LSM 之间没有相关性,且相关性较弱。结论:在这个多民族人群中,27.3%的人出现了肝脂肪变性的升高。在土耳其背景和 2 型糖尿病患者中,脂肪变性和纤维化的指标较高,而在加纳背景下,NITs 通常较低。总的来说,这表明需要在高危人群中提高对 NAFLD 的认识,并考虑到种族背景。FIB-4 和 APRI 与 LSM 之间缺乏明确的相关性,这使得这些纤维化 NITs 在一般人群中检测晚期纤维化的准确性受到质疑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe4/9827962/dc5472cfe879/hc9-7-e2109-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验